PANACEABIO — Panacea Biotec Share Price
0.000.00%
Last trade - 00:00- IN₹32.91bn
- IN₹31.06bn
- IN₹5.59bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 3.83 | ||
| Price to Tang. Book | 4 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 5.67 | ||
| EV to EBITDA | 504.8 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -3.2% | ||
| Return on Equity | -0.97% | ||
| Operating Margin | -5.19% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 5,440.62 | 6,248.05 | 6,612.32 | 4,599.46 | 5,591.68 | n/a | n/a | 4.13% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Panacea Biotec Limited is an India-based pharmaceutical and biotechnology company with research, manufacturing and marketing capabilities. The Company is engaged in the business of research, development, manufacture and marketing of branded vaccines, pharmaceutical formulations, nutraceuticals and food and nutrition products in India and international markets. Its segments include vaccines and formulations. It has specialized in the development of fully liquid combination vaccines that can be stored at 2-8 degree Celsius temperature. Its vaccine portfolio includes EasySix (DTwP-Hib-HepB-IPV), EasyFive-TITM (DTwP-Hib-HepB), EasyFour-TI (DTwP-Hib), EasyFourPol (DTwP-IPV) and Bivalent oral polio vaccine (type-1 and type-3). Its pipeline vaccines include NucoVac 11, DengiALL and Td (tetanus and diphtheria - reduced). Its pharmaceutical formulation products include Sitcom Tablets and Sitcom Cream. Its nutrition product brand names include ChilRunfull, ChilRun 7+ and ChilRun NoSucrose.
Directors
- Soshil Jain CHM (79)
- Devender Gupta CFO
- Vinod Goel CCO (47)
- Rajesh Jain MDR (48)
- Sandeep Jain MDR (46)
- Ankesh Jain EDR
- Partha De OTH
- Shantanu Nalavadi DRC
- Nithin Kaimal NED
- Sunil Kapoor NED (56)
- Mukul Gupta NID
- Namdeo Khamitkar NID (73)
- Krishna Lal NID (81)
- Raghava Narasimhan NID (73)
- Bhupinder Singh NID
- Manjula Upadhyay NID
- Last Annual
- March 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- February 2nd, 1984
- Public Since
- September 25th, 1995
- No. of Shareholders
- 46,242
- No. of Employees
- 1,146
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- National Stock Exchange of India
- Shares in Issue
- 61,250,746
- Address
- B-1 Extn / G-3, NEW DELHI, 110044
- Web
- https://www.panaceabiotec.com/
- Phone
- +91 1141679000
- Auditors
- Walker Chandiok & Co LLP
Upcoming Events for PANACEABIO
Q1 2026 Panacea Biotec Ltd Earnings Release
Panacea Biotec Ltd Annual Shareholders Meeting
Similar to PANACEABIO
Aarey Drugs and Pharmaceuticals
National Stock Exchange of India
Aarti Drugs
National Stock Exchange of India
Aarti Pharmalabs
National Stock Exchange of India
Abbott India
National Stock Exchange of India
Accent Microcell
National Stock Exchange of India
FAQ
What is the Panacea Biotec share price?
As of Today at 22:33 UTC, shares in Panacea Biotec are trading at IN₹520.80. This share price information is delayed by 15 minutes.
How has the Panacea Biotec share price performed this year?
Shares in Panacea Biotec last closed at IN₹520.80 and the price had moved by +255.49% over the past 365 days. In terms of relative price strength the Panacea Biotec share price has outperformed the S&P BSE 100 Index by +234.88% over the past year.
What are the analyst and broker recommendations for Panacea Biotec?
There is no consensus recommendation for this security.
Find out moreWhat is the Panacea Biotec dividend yield?
Panacea Biotec does not currently pay a dividend.
Does Panacea Biotec pay a dividend?
Panacea Biotec does not currently pay a dividend.
When does Panacea Biotec next pay dividends?
Panacea Biotec does not currently pay a dividend.
How do I buy Panacea Biotec shares?
To buy shares in Panacea Biotec you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Panacea Biotec?
As of the previous close price of IN₹520.80, shares in Panacea Biotec had a market capitalisation of IN₹32.91bn.
Where are Panacea Biotec shares listed?
Here are the trading details for Panacea Biotec:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: PANACEABIO
What kind of share is Panacea Biotec?
Based on an overall assessment of its quality, value and momentum Panacea Biotec is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Panacea Biotec share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Panacea Biotec share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Panacea Biotec. Over the past six months, its share price has outperformed the S&P BSE 100 Index by +88.02%.
As of the last closing price of IN₹520.80, shares in Panacea Biotec were trading +54.19% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Panacea Biotec PE Ratio?
The Panacea Biotec PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹520.80.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Panacea Biotec?
Panacea Biotec's management team is headed by:
- Soshil Jain - CHM
- Devender Gupta - CFO
- Vinod Goel - CCO
- Rajesh Jain - MDR
- Sandeep Jain - MDR
- Ankesh Jain - EDR
- Partha De - OTH
- Shantanu Nalavadi - DRC
- Nithin Kaimal - NED
- Sunil Kapoor - NED
- Mukul Gupta - NID
- Namdeo Khamitkar - NID
- Krishna Lal - NID
- Raghava Narasimhan - NID
- Bhupinder Singh - NID
- Manjula Upadhyay - NID